NicholasCyrilDcunhaMDFACP,

Head & Neck Cancer, Hematologic Oncology, Melanoma, Neuro-Oncology

Associate Professor, Texas Tech University, HSC University Medical Center. Attending

Dr. Dcunha is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
602 Indiana Ave
Lubbock, TX 79415
Phone+1 806-775-8600

Fax+1 806-775-8602

Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1995
Rutgers Health/Jersey City Medical CenterResidency, Internal Medicine, 1992
Rutgers Health/Jersey City Medical CenterInternship, Internal Medicine, 1989 - 1990
Topiwala National Medical CollegeClass of 1981

PubMed

57 citations
Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.
Jose A. Figueroa, Adair Reidy, Leonardo Mirandola, Kayley Trotter, Natallia Suvorava
International Reviews of Immunology. 2015-04-22
11 citations
Sigmoid plasmacytoma mimicking colon cancer in a patient with multiple myeloma: case report and review of literature
Sameer Islam, Mohamed Attaya, Sreeram Parupudi, Ebtesam Islam, Nicholas D'Cunha
Gastrointestinal Endoscopy. 2010-03-01
45 citations
Gamma-radiation upregulates MHC class I/II and ICAM-I molecules in multiple myeloma cell lines and primary tumors
Maurizio Chiriva-Internati, Fabio Grizzi, Justin Pinkston, K. John Morrow, Nicholas D'Cunha
In Vitro Cellular & Developmental Biology. Animal. 2006-03-01

Abstracts/Posters

Tolerability in Patients with Multiple Myeloma Treated with Daratumumab: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials
Nicholas D'Cunha, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Updated Meta-Analysis of Randomized Controlled Trials to Evaluate the Incidence of Infection and Pneumonia in Patients with Multiple Myeloma Treated with Daratumumab
Nicholas D'Cunha, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Daratumumab-Related Hematological Toxicities in Patients with Multiple Myeloma: A Combined Analysis of Five Phase III Randomized Controlled Trials
Nicholas D'Cunha, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Efficacy of Upfront Daratumumab Combination Regimen in Patients with Newly Diagnosed Multiple Myeloma
Nicholas D'Cunha, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Updated Meta-Analysis to Evaluate the Incidence of Atrial Fibrillation and Major Bleeding in Patients with Hematologic Malignancies Treated with Ibrutinib
Nicholas D'Cunha, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Join now to see all